Syremis Therapeutics: Careers, Salary, Culture & Funding

Sure. Syremis Therapeutics is a Cambridge-based company that focuses on Neuropsychiatric drug development. They were founded in 2023 and have been building their team in the Healthcare / Nursing space ever since. The company’s leadership team has not been publicly disclosed. Right now the company has around 30 people on staff.

At its core, Syremis Therapeutics is working on Neuropsychiatric drug development. Think of it this way — the Healthcare / Nursing industry has real challenges that traditional approaches haven’t fully solved, and Syremis Therapeutics is trying to tackle those gaps. They’ve been able to attract serious funding, which suggests investors believe the approach has potential. The company is still relatively young, having launched in 2023, so they’re in that phase where the product is evolving quickly.

The company hasn’t publicly named its CEO, which isn’t unusual for early-stage startups that prefer to keep a lower profile. The team is based primarily in Cambridge, MA, and at around 30 employees, it’s still small enough that leadership is likely accessible to most team members.

Syremis Therapeutics has raised $165 million to date, with the most recent round being a Series A. Their investor list includes Undisclosed. That’s a solid group of backers, and the funding level tells you that outside parties have done their due diligence and believe in what the company is building.

It matters more than people think. A company with $165M in the bank isn’t scrambling to make payroll — it has runway to invest in its team, tools, and growth. For you as a potential employee, that usually means competitive compensation, better resources, and less risk of sudden layoffs. It also means they’re probably hiring, which gives you more leverage in negotiations. That said, funding alone doesn’t guarantee a great workplace, so always do your own research.

With a team of about 30 people, Syremis Therapeutics is at the stage where they need a mix of both. You’d expect to see roles in engineering, product, and R&D given their focus on Neuropsychiatric drug development, but companies this size also hire for operations, marketing, sales, and general business functions. Check their careers page for current openings — the mix changes as priorities shift.

At 30 employees, you’re going to feel the startup energy — things move fast, roles can overlap, and you’ll likely wear multiple hats. The upside is that you’ll have real visibility and impact. Being in Cambridge puts them in a strong talent market, which usually means the team around you will be sharp. One thing to keep in mind: early-stage companies can be exciting, but the pace isn’t for everyone. I’d recommend reaching out to current employees on LinkedIn to get a candid take before applying.